Entry signal 21.16, stop 17.43. First target 29.83
The stock is showing a good wave structure It has a bit of spiky pullback during its wave 4 The candles have broken the highs and failed a few times Apart from the above, it's looking really good for another push-up I've lost 0.5R on it once. If this second and final attempt goes well then I will recover the previous investment and plus 1R on top. So here we...
Here we have another stock with a lovely wave 3 up a nice not too complex wave 4 down price has squeezed into a tight box allowing us to take a tight 3 dollar stop Entry Price $21 Stop $18 (or maybe even 18.50) Target 1: $23.50 Target 2: $26 Fingers Crossed!!! Company Profile Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the...
OCUL OCUL has a pattern of descending triangles over the past 4-months (July-November 2019). The company launched its second commercial product Dextenza in the 2nd quarter where it gave away free samples. Its other product 'ReSure Sealent' has posted weak sales numbers ($472K in 1Q19 and ~600K in 2Q19). Dextenza is priced at $850 and is essentially an...
Bearish head and shoulders setup. Most likely no sales. I will look to add after retracement. Potential AB=BC harmonic correction. Disclosure: I do not own shares of OCUL. This is not a note to buy or sell. please do your hw before investing.
Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline include Dextenza, OTX-TP, and OTX-TIC . The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA. SHORT...
This channel is a mess , for the longer as I am. Is it to the end? Divergence on RSI and MACD let me think so , wait and see
-the titile is moving on the bottom of a ascending channel -on daily is forming a double bottom
OCU was in our smart money watch list as it had Big insider buying on the 13th of August. It also seems forming a fallen angel formation. We think it has good upside potential. John sent an intraday text alert on August 14th while this was at $6.35 indicating a possible entry zone. This has continued to hold and is something we continue to like as a long idea.
really great chart setup here. RSI heading up. MACD crossover. looking for uptrend from here on.
OCUL has broken this small degree downtrend. If the level posted on chart holds i'm expectiong one more wave up. Put an eye on earnings (3/9/2017) for a potential catalyst for the next move. A strong breakdown under the level posted on chart invalidates this setup.
OCUL is moving upward after a huge decline followed by long consolidation. Break of 5.57 will be a long entry confirmation & our target is the just below gap down support at 6.43.